Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Security

BiondVax Pharmaceuticals Ltd. · BVXVW

BVXVWNASDAQWarrantHistorical · closed May 14, 2020CIK 1611747Updated Nov 18, 2026

Company: Scinai Immunotherapeutics Ltd. →

Name history
BiondVax Pharmaceuticals Ltd. · through Aug 28, 2023

BVXVW price & chart

Provider market data
Historical security

This listing closed May 14, 2020. Live provider charts are shown only for current listings.

About the company

We are a biopharmaceutical company focused on the development of innovative immunology therapies and the operation of a contract development and manufacturing organization. We are advancing a pipeline of therapeutic candidates licensed from the Max Planck Society. We also own Scinai Biopharma Services Ltd., a contract development and manufacturing organization (CDMO), providing development and manufacturing services to biotechnology and pharmaceutical companies.

F-1 · 2026-09-24 · 0001213900-26-103067

Company description from the cited filing.

In the news

No coverage from other publishers is available.

Recent filings

  1. 6-K filing

    6-K · 2026-11-17 · 0001213900-26-121090

  2. 424B3 filing

    424B3 · 2026-11-10 · 0001213900-26-117817

  3. EFFECT filing

    EFFECT · 2026-11-09 · 9999999995-26-003484

  4. 6-K filing

    6-K · 2026-11-09 · 0001213900-26-117154

  5. F-3 filing

    F-3 · 2026-10-28 · 0001213900-26-113294

Show 5 more recent filings
  1. 6-K filing

    6-K · 2026-10-20 · 0001213900-26-110869

  2. 6-K filing

    6-K · 2026-10-16 · 0001213900-26-110069

  3. 6-K filing

    6-K · 2026-10-15 · 0001213900-26-109633

  4. 6-K filing

    6-K · 2026-10-13 · 0001213900-26-108730

  5. EFFECT filing

    EFFECT · 2026-10-05 · 9999999995-26-003155

Financials

FY 2025 · USD
Revenue1,311,000USD · FY 2025
Source

20-F · 2026-04-01 · 0001213900-26-038011

2025-01-01 to 2025-12-31

Net income-8,307,000USD · FY 2025
Source

20-F · 2026-04-01 · 0001213900-26-038011

2025-01-01 to 2025-12-31

Operating income-7,542,000USD · FY 2025
Source

20-F · 2026-04-01 · 0001213900-26-038011

2025-01-01 to 2025-12-31

Diluted EPS— · FY 2025

Some figures are unavailable for this reporting year.

balance sheet · annual statements
Line itemQ3 2021Q2 2025Q2 2024Q2 2023Q2 2022Q2 2021Q1 2023Q1 2022FY 2025FY 2024FY 2023FY 2022
ASSETS
AssetsUSD25,093,000
Source

6-K/A · 2021-12-27 · 0001213900-21-067430

As of 2021-09-30

11,840,000
Source

6-K · 2025-09-02 · 0001213900-25-083373

As of 2025-06-30

14,851,000
Source

6-K · 2024-09-09 · 0001213900-24-076707

As of 2024-06-30

19,897,000
Source

6-K/A · 2023-08-18 · 0001213900-23-068745

As of 2023-06-30

24,449,000
Source

6-K/A · 2022-08-29 · 0001213900-22-051844

As of 2022-06-30

88,049,000
Source

6-K/A · 2022-08-29 · 0001213900-22-051844

As of 2021-06-30

23,292,000
Source

10-Q · 2023-05-15 · 0001213900-23-039875

As of 2023-03-31

—11,626,000
Source

20-F · 2026-04-01 · 0001213900-26-038011

As of 2025-12-31

13,448,000
Source

20-F · 2025-05-07 · 0001213900-25-040402

As of 2024-12-31

17,472,000
Source

20-F · 2024-05-15 · 0001213900-24-043560

As of 2023-12-31

27,067,000
Source

10-K · 2023-04-17 · 0001213900-23-030228

As of 2022-12-31

Property, Plant and Equipment, NetUSD—8,497,000
Source

6-K · 2025-09-02 · 0001213900-25-083373

As of 2025-06-30

10,180,000
Source

6-K · 2024-09-09 · 0001213900-24-076707

As of 2024-06-30

10,802,000
Source

6-K/A · 2023-08-18 · 0001213900-23-068745

As of 2023-06-30

——10,817,000
Source

10-Q · 2023-05-15 · 0001213900-23-039875

As of 2023-03-31

—7,793,000
Source

20-F · 2026-04-01 · 0001213900-26-038011

As of 2025-12-31

9,189,000
Source

20-F · 2025-05-07 · 0001213900-25-040402

As of 2024-12-31

10,825,000
Source

20-F · 2024-05-15 · 0001213900-24-043560

As of 2023-12-31

11,245,000
Source

10-K · 2023-04-17 · 0001213900-23-030228

As of 2022-12-31

Current assets:
Cash and Cash Equivalents, at Carrying ValueUSD—989,000
Source

6-K · 2025-09-02 · 0001213900-25-083373

As of 2025-06-30

3,076,000
Source

6-K · 2025-09-02 · 0001213900-25-083373

As of 2024-06-30

7,506,000
Source

6-K · 2024-09-09 · 0001213900-24-076707

As of 2023-06-30

11,285,000
Source

6-K/A · 2023-08-18 · 0001213900-23-068745

As of 2022-06-30

—10,799,000
Source

10-Q · 2023-05-15 · 0001213900-23-039875

As of 2023-03-31

15,392,000
Source

10-Q · 2023-05-15 · 0001213900-23-039875

As of 2022-03-31

1,661,000
Source

20-F · 2026-04-01 · 0001213900-26-038011

As of 2025-12-31

1,964,000
Source

20-F · 2025-05-07 · 0001213900-25-040402

As of 2024-12-31

4,870,000
Source

20-F · 2024-05-15 · 0001213900-24-043560

As of 2023-12-31

14,075,000
Source

10-K · 2023-04-17 · 0001213900-23-030228

As of 2022-12-31

Accounts Receivable, after Allowance for Credit Loss, CurrentUSD—139,000
Source

6-K · 2025-09-02 · 0001213900-25-083373

As of 2025-06-30

119,000
Source

6-K · 2024-09-09 · 0001213900-24-076707

As of 2024-06-30

—————73,000
Source

20-F · 2026-04-01 · 0001213900-26-038011

As of 2025-12-31

83,000
Source

20-F · 2025-05-07 · 0001213900-25-040402

As of 2024-12-31

——
Assets, CurrentUSD—1,506,000
Source

6-K · 2025-09-02 · 0001213900-25-083373

As of 2025-06-30

3,657,000
Source

6-K · 2024-09-09 · 0001213900-24-076707

As of 2024-06-30

7,770,000
Source

6-K/A · 2023-08-18 · 0001213900-23-068745

As of 2023-06-30

——11,045,000
Source

10-Q · 2023-05-15 · 0001213900-23-039875

As of 2023-03-31

—2,054,000
Source

20-F · 2026-04-01 · 0001213900-26-038011

As of 2025-12-31

2,391,000
Source

20-F · 2025-05-07 · 0001213900-25-040402

As of 2024-12-31

5,447,000
Source

20-F · 2024-05-15 · 0001213900-24-043560

As of 2023-12-31

14,370,000
Source

10-K · 2023-04-17 · 0001213900-23-030228

As of 2022-12-31

Prepaid Expense and Other Assets, CurrentUSD—236,000
Source

6-K · 2025-09-02 · 0001213900-25-083373

As of 2025-06-30

324,000
Source

6-K · 2024-09-09 · 0001213900-24-076707

As of 2024-06-30

138,000
Source

6-K/A · 2023-08-18 · 0001213900-23-068745

As of 2023-06-30

————170,000
Source

20-F · 2026-04-01 · 0001213900-26-038011

As of 2025-12-31

213,000
Source

20-F · 2025-05-07 · 0001213900-25-040402

As of 2024-12-31

437,000
Source

20-F · 2024-05-15 · 0001213900-24-043560

As of 2023-12-31

45,000
Source

10-K · 2023-04-17 · 0001213900-23-030228

As of 2022-12-31

Operating Lease, Right-of-Use AssetUSD—1,837,000
Source

6-K · 2025-09-02 · 0001213900-25-083373

As of 2025-06-30

1,014,000
Source

6-K · 2024-09-09 · 0001213900-24-076707

As of 2024-06-30

1,325,000
Source

6-K/A · 2023-08-18 · 0001213900-23-068745

As of 2023-06-30

——1,430,000
Source

10-Q · 2023-05-15 · 0001213900-23-039875

As of 2023-03-31

—1,779,000
Source

20-F · 2026-04-01 · 0001213900-26-038011

As of 2025-12-31

1,868,000
Source

20-F · 2025-05-07 · 0001213900-25-040402

As of 2024-12-31

1,200,000
Source

20-F · 2024-05-15 · 0001213900-24-043560

As of 2023-12-31

1,452,000
Source

10-K · 2023-04-17 · 0001213900-23-030228

As of 2022-12-31

LIABILITIES AND EQUITY
Stockholders’ equity:
Preferred Stock, Value, IssuedUSD—5,627,000
Source

6-K · 2025-09-02 · 0001213900-25-083373

As of 2025-06-30

——————5,627,000
Source

20-F · 2026-04-01 · 0001213900-26-038011

As of 2025-12-31

5,627,000
Source

20-F · 2025-05-07 · 0001213900-25-040402

As of 2024-12-31

——
Additional Paid in CapitalUSD—125,644,000
Source

6-K · 2025-09-02 · 0001213900-25-083373

As of 2025-06-30

121,272,000
Source

6-K · 2024-09-09 · 0001213900-24-076707

As of 2024-06-30

117,740,000
Source

6-K/A · 2023-08-18 · 0001213900-23-068745

As of 2023-06-30

——116,431,000
Source

10-Q · 2023-05-15 · 0001213900-23-039875

As of 2023-03-31

—130,062,000
Source

20-F · 2026-04-01 · 0001213900-26-038011

As of 2025-12-31

123,629,000
Source

20-F · 2025-05-07 · 0001213900-25-040402

As of 2024-12-31

119,506,000
Source

20-F · 2024-05-15 · 0001213900-24-043560

As of 2023-12-31

116,082,000
Source

10-K · 2023-04-17 · 0001213900-23-030228

As of 2022-12-31

Retained Earnings (Accumulated Deficit)USD—-121,673,000
Source

6-K · 2025-09-02 · 0001213900-25-083373

As of 2025-06-30

-126,816,000
Source

6-K · 2024-09-09 · 0001213900-24-076707

As of 2024-06-30

-123,112,000
Source

6-K/A · 2023-08-18 · 0001213900-23-068745

As of 2023-06-30

——-119,350,000
Source

10-Q · 2023-05-15 · 0001213900-23-039875

As of 2023-03-31

—-125,846,000
Source

20-F · 2026-04-01 · 0001213900-26-038011

As of 2025-12-31

-117,539,000
Source

20-F · 2025-05-07 · 0001213900-25-040402

As of 2024-12-31

-122,335,000
Source

20-F · 2024-05-15 · 0001213900-24-043560

As of 2023-12-31

-115,835,000
Source

10-K · 2023-04-17 · 0001213900-23-030228

As of 2022-12-31

Accumulated Other Comprehensive Income (Loss), Net of TaxUSD—-1,740,000
Source

6-K · 2025-09-02 · 0001213900-25-083373

As of 2025-06-30

-1,740,000
Source

6-K · 2024-09-09 · 0001213900-24-076707

As of 2024-06-30

-1,740,000
Source

6-K/A · 2023-08-18 · 0001213900-23-068745

As of 2023-06-30

——-1,891,000
Source

10-Q · 2023-05-15 · 0001213900-23-039875

As of 2023-03-31

—-1,740,000
Source

20-F · 2026-04-01 · 0001213900-26-038011

As of 2025-12-31

-1,740,000
Source

20-F · 2025-05-07 · 0001213900-25-040402

As of 2024-12-31

-1,740,000
Source

20-F · 2024-05-15 · 0001213900-24-043560

As of 2023-12-31

-2,007,000
Source

10-K · 2023-04-17 · 0001213900-23-030228

As of 2022-12-31

Stockholders' Equity Attributable to ParentUSD—7,858,000
Source

6-K · 2025-09-02 · 0001213900-25-083373

As of 2025-06-30

-7,284,000
Source

6-K · 2025-09-02 · 0001213900-25-083373

As of 2024-06-30

-7,112,000
Source

6-K · 2024-09-09 · 0001213900-24-076707

As of 2023-06-30

3,264,000
Source

6-K/A · 2023-08-18 · 0001213900-23-068745

As of 2022-06-30

—-4,810,000
Source

10-Q · 2023-05-15 · 0001213900-23-039875

As of 2023-03-31

-862,000
Source

10-Q · 2023-05-15 · 0001213900-23-039875

As of 2022-03-31

8,103,000
Source

20-F · 2026-04-01 · 0001213900-26-038011

As of 2025-12-31

9,977,000
Source

20-F · 2025-05-07 · 0001213900-25-040402

As of 2024-12-31

-4,569,000
Source

20-F · 2024-05-15 · 0001213900-24-043560

As of 2023-12-31

-1,760,000
Source

10-K · 2023-04-17 · 0001213900-23-030228

As of 2022-12-31

Liabilities and EquityUSD—11,840,000
Source

6-K · 2025-09-02 · 0001213900-25-083373

As of 2025-06-30

14,851,000
Source

6-K · 2024-09-09 · 0001213900-24-076707

As of 2024-06-30

19,897,000
Source

6-K/A · 2023-08-18 · 0001213900-23-068745

As of 2023-06-30

——23,292,000
Source

10-Q · 2023-05-15 · 0001213900-23-039875

As of 2023-03-31

—11,626,000
Source

20-F · 2026-04-01 · 0001213900-26-038011

As of 2025-12-31

13,448,000
Source

20-F · 2025-05-07 · 0001213900-25-040402

As of 2024-12-31

17,472,000
Source

20-F · 2024-05-15 · 0001213900-24-043560

As of 2023-12-31

27,067,000
Source

10-K · 2023-04-17 · 0001213900-23-030228

As of 2022-12-31

Current liabilities:
Liabilities, CurrentUSD—2,120,000
Source

6-K · 2025-09-02 · 0001213900-25-083373

As of 2025-06-30

1,672,000
Source

6-K · 2024-09-09 · 0001213900-24-076707

As of 2024-06-30

1,888,000
Source

6-K/A · 2023-08-18 · 0001213900-23-068745

As of 2023-06-30

——2,579,000
Source

10-Q · 2023-05-15 · 0001213900-23-039875

As of 2023-03-31

—1,585,000
Source

20-F · 2026-04-01 · 0001213900-26-038011

As of 2025-12-31

1,806,000
Source

20-F · 2025-05-07 · 0001213900-25-040402

As of 2024-12-31

1,780,000
Source

20-F · 2024-05-15 · 0001213900-24-043560

As of 2023-12-31

2,338,000
Source

10-K · 2023-04-17 · 0001213900-23-030228

As of 2022-12-31

Operating Lease, Liability, CurrentUSD—497,000
Source

6-K · 2025-09-02 · 0001213900-25-083373

As of 2025-06-30

364,000
Source

6-K · 2024-09-09 · 0001213900-24-076707

As of 2024-06-30

394,000
Source

6-K/A · 2023-08-18 · 0001213900-23-068745

As of 2023-06-30

————329,000
Source

20-F · 2026-04-01 · 0001213900-26-038011

As of 2025-12-31

424,000
Source

20-F · 2025-05-07 · 0001213900-25-040402

As of 2024-12-31

396,000
Source

20-F · 2024-05-15 · 0001213900-24-043560

As of 2023-12-31

—
Operating Lease, Liability, NoncurrentUSD—1,566,000
Source

6-K · 2025-09-02 · 0001213900-25-083373

As of 2025-06-30

640,000
Source

6-K · 2024-09-09 · 0001213900-24-076707

As of 2024-06-30

927,000
Source

6-K/A · 2023-08-18 · 0001213900-23-068745

As of 2023-06-30

——1,008,000
Source

10-Q · 2023-05-15 · 0001213900-23-039875

As of 2023-03-31

—1,644,000
Source

20-F · 2026-04-01 · 0001213900-26-038011

As of 2025-12-31

1,402,000
Source

20-F · 2025-05-07 · 0001213900-25-040402

As of 2024-12-31

797,000
Source

20-F · 2024-05-15 · 0001213900-24-043560

As of 2023-12-31

1,078,000
Source

10-K · 2023-04-17 · 0001213900-23-030228

As of 2022-12-31

Additional Financial Items
Accrued Liabilities, CurrentUSD————————441,000
Source

20-F · 2026-04-01 · 0001213900-26-038011

As of 2025-12-31

527,000
Source

20-F · 2025-05-07 · 0001213900-25-040402

As of 2024-12-31

461,000
Source

20-F · 2024-05-15 · 0001213900-24-043560

As of 2023-12-31

756,000
Source

10-K · 2023-04-17 · 0001213900-23-030228

As of 2022-12-31

Deferred Revenue, CurrentUSD————————90,000
Source

20-F · 2026-04-01 · 0001213900-26-038011

As of 2025-12-31

225,000
Source

20-F · 2025-05-07 · 0001213900-25-040402

As of 2024-12-31

——
Deferred Tax Liabilities, NetUSD————————409,000
Source

20-F · 2026-04-01 · 0001213900-26-038011

As of 2025-12-31

284,000
Source

20-F · 2025-05-07 · 0001213900-25-040402

As of 2024-12-31

217,000
Source

20-F · 2024-05-15 · 0001213900-24-043560

As of 2023-12-31

—
TradeAndOtherCurrentPayables—
Source

6-K/A · 2021-12-27 · 0001213900-21-067430

As of 2021-09-30

————
Source

6-K/A · 2022-08-29 · 0001213900-22-051844

As of 2022-06-30

—
Source

6-K/A · 2022-08-29 · 0001213900-22-051844

As of 2021-06-30

——————
TradeAndOtherCurrentReceivables—
Source

6-K/A · 2021-12-27 · 0001213900-21-067430

As of 2021-09-30

————
Source

6-K/A · 2022-08-29 · 0001213900-22-051844

As of 2022-06-30

—
Source

6-K/A · 2022-08-29 · 0001213900-22-051844

As of 2021-06-30

——————

Lines labelled “Derived” are calculated from reported figures.

cash flow · annual statements
Line itemQ4 2021Q3 2021Q2 2025Q2 2024Q2 2023Q2 2022Q1 2023Q1 2022FY 2025FY 2024FY 2023FY 2022
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, Depletion and AmortizationUSD——————138,000
Source

10-Q · 2023-05-15 · 0001213900-23-039875

2023-01-01 to 2023-03-31

134,000
Source

10-Q · 2023-05-15 · 0001213900-23-039875

2022-01-01 to 2022-03-31

1,421,000
Source

20-F · 2026-04-01 · 0001213900-26-038011

2025-01-01 to 2025-12-31

1,649,000
Source

20-F · 2025-05-07 · 0001213900-25-040402

2024-01-01 to 2024-12-31

514,000
Source

20-F · 2024-05-15 · 0001213900-24-043560

2023-01-01 to 2023-12-31

562,000
Source

10-K · 2023-04-17 · 0001213900-23-030228

2022-01-01 to 2022-12-31

Share-based Payment Arrangement, Noncash ExpenseUSD——————252,000
Source

10-Q · 2023-05-15 · 0001213900-23-039875

2023-01-01 to 2023-03-31

485,000
Source

10-Q · 2023-05-15 · 0001213900-23-039875

2022-01-01 to 2022-03-31

303,000
Source

20-F · 2026-04-01 · 0001213900-26-038011

2025-01-01 to 2025-12-31

682,000
Source

20-F · 2025-05-07 · 0001213900-25-040402

2024-01-01 to 2024-12-31

1,139,000
Source

20-F · 2024-05-15 · 0001213900-24-043560

2023-01-01 to 2023-12-31

1,602,000
Source

10-K · 2023-04-17 · 0001213900-23-030228

2022-01-01 to 2022-12-31

Changes in operating assets and liabilities:
Increase (Decrease) in Accounts ReceivableUSD————————-10,000
Source

20-F · 2026-04-01 · 0001213900-26-038011

2025-01-01 to 2025-12-31

83,000
Source

20-F · 2025-05-07 · 0001213900-25-040402

2024-01-01 to 2024-12-31

——
Net Cash Provided by (Used in) Operating ActivitiesUSD——————-3,059,000
Source

10-Q · 2023-05-15 · 0001213900-23-039875

2023-01-01 to 2023-03-31

-1,105,000
Source

10-Q · 2023-05-15 · 0001213900-23-039875

2022-01-01 to 2022-03-31

-6,031,000
Source

20-F · 2026-04-01 · 0001213900-26-038011

2025-01-01 to 2025-12-31

-6,335,000
Source

20-F · 2025-05-07 · 0001213900-25-040402

2024-01-01 to 2024-12-31

-9,382,000
Source

20-F · 2024-05-15 · 0001213900-24-043560

2023-01-01 to 2023-12-31

-7,265,000
Source

10-K · 2023-04-17 · 0001213900-23-030228

2022-01-01 to 2022-12-31

Cash flows from investing activities:
Net Cash Provided by (Used in) Investing ActivitiesUSD——————-6,000
Source

10-Q · 2023-05-15 · 0001213900-23-039875

2023-01-01 to 2023-03-31

-521,000
Source

10-Q · 2023-05-15 · 0001213900-23-039875

2022-01-01 to 2022-03-31

-24,000
Source

20-F · 2026-04-01 · 0001213900-26-038011

2025-01-01 to 2025-12-31

-12,000
Source

20-F · 2025-05-07 · 0001213900-25-040402

2024-01-01 to 2024-12-31

-637,000
Source

20-F · 2024-05-15 · 0001213900-24-043560

2023-01-01 to 2023-12-31

-836,000
Source

10-K · 2023-04-17 · 0001213900-23-030228

2022-01-01 to 2022-12-31

Payments to Acquire Property, Plant, and EquipmentUSD——————6,000
Source

10-Q · 2023-05-15 · 0001213900-23-039875

2023-01-01 to 2023-03-31

521,000
Source

10-Q · 2023-05-15 · 0001213900-23-039875

2022-01-01 to 2022-03-31

24,000
Source

20-F · 2026-04-01 · 0001213900-26-038011

2025-01-01 to 2025-12-31

12,000
Source

20-F · 2025-05-07 · 0001213900-25-040402

2024-01-01 to 2024-12-31

637,000
Source

20-F · 2024-05-15 · 0001213900-24-043560

2023-01-01 to 2023-12-31

836,000
Source

10-K · 2023-04-17 · 0001213900-23-030228

2022-01-01 to 2022-12-31

Cash flows from financing activities:
Net Cash Provided by (Used in) Financing ActivitiesUSD————————5,770,000
Source

20-F · 2026-04-01 · 0001213900-26-038011

2025-01-01 to 2025-12-31

3,441,000
Source

20-F · 2025-05-07 · 0001213900-25-040402

2024-01-01 to 2024-12-31

1,086,000
Source

20-F · 2024-05-15 · 0001213900-24-043560

2023-01-01 to 2023-12-31

6,776,000
Source

10-K · 2023-04-17 · 0001213900-23-030228

2022-01-01 to 2022-12-31

Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD——————-3,289,000
Source

10-Q · 2023-05-15 · 0001213900-23-039875

2023-01-01 to 2023-03-31

-1,985,000
Source

10-Q · 2023-05-15 · 0001213900-23-039875

2022-01-01 to 2022-03-31

-284,000
Source

20-F · 2026-04-01 · 0001213900-26-038011

2025-01-01 to 2025-12-31

-2,915,000
Source

20-F · 2025-05-07 · 0001213900-25-040402

2024-01-01 to 2024-12-31

-9,205,000
Source

20-F · 2024-05-15 · 0001213900-24-043560

2023-01-01 to 2023-12-31

-3,302,000
Source

10-K · 2023-04-17 · 0001213900-23-030228

2022-01-01 to 2022-12-31

Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD——1,131,000
Source

6-K · 2025-09-02 · 0001213900-25-083373

As of 2025-06-30

3,214,000
Source

6-K · 2025-09-02 · 0001213900-25-083373

As of 2024-06-30

7,632,000
Source

6-K · 2024-09-09 · 0001213900-24-076707

As of 2023-06-30

11,423,000
Source

6-K/A · 2023-08-18 · 0001213900-23-068745

As of 2022-06-30

10,926,000
Source

10-Q · 2023-05-15 · 0001213900-23-039875

As of 2023-03-31

15,532,000
Source

10-Q · 2023-05-15 · 0001213900-23-039875

As of 2022-03-31

1,811,000
Source

20-F · 2026-04-01 · 0001213900-26-038011

As of 2025-12-31

2,095,000
Source

20-F · 2025-05-07 · 0001213900-25-040402

As of 2024-12-31

5,010,000
Source

20-F · 2024-05-15 · 0001213900-24-043560

As of 2023-12-31

14,215,000
Source

10-K · 2023-04-17 · 0001213900-23-030228

As of 2022-12-31

Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD——————725,000
Source

10-Q · 2023-05-15 · 0001213900-23-039875

2023-01-01 to 2023-03-31

——143,000
Source

20-F · 2025-05-07 · 0001213900-25-040402

2024-01-01 to 2024-12-31

833,000
Source

20-F · 2024-05-15 · 0001213900-24-043560

2023-01-01 to 2023-12-31

916,000
Source

10-K · 2023-04-17 · 0001213900-23-030228

2022-01-01 to 2022-12-31

Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD——————-224,000
Source

10-Q · 2023-05-15 · 0001213900-23-039875

2023-01-01 to 2023-03-31

-359,000
Source

10-Q · 2023-05-15 · 0001213900-23-039875

2022-01-01 to 2022-03-31

1,000
Source

20-F · 2026-04-01 · 0001213900-26-038011

2025-01-01 to 2025-12-31

-9,000
Source

20-F · 2025-05-07 · 0001213900-25-040402

2024-01-01 to 2024-12-31

-272,000
Source

20-F · 2024-05-15 · 0001213900-24-043560

2023-01-01 to 2023-12-31

—
Additional Financial Items
Share-based Payment Arrangement, ExpenseUSD——————252,000
Source

10-Q · 2023-05-15 · 0001213900-23-039875

2023-01-01 to 2023-03-31

485,000
Source

10-Q · 2023-05-15 · 0001213900-23-039875

2022-01-01 to 2022-03-31

304,000
Source

20-F · 2026-04-01 · 0001213900-26-038011

2025-01-01 to 2025-12-31

682,000
Source

20-F · 2025-05-07 · 0001213900-25-040402

2024-01-01 to 2024-12-31

——
DepreciationUSD————————1,420,000
Source

20-F · 2026-04-01 · 0001213900-26-038011

2025-01-01 to 2025-12-31

1,648,000
Source

20-F · 2025-05-07 · 0001213900-25-040402

2024-01-01 to 2024-12-31

—562,000
Source

10-K · 2023-04-17 · 0001213900-23-030228

2022-01-01 to 2022-12-31

General and Administrative ExpenseUSD—6,201,000
Source

6-K/A · 2021-12-27 · 0001213900-21-067430

2021-07-01 to 2021-09-30

——1,141,000
Source

6-K/A · 2023-08-18 · 0001213900-23-068745

2023-04-01 to 2023-06-30

1,289,000
Source

6-K/A · 2023-08-18 · 0001213900-23-068745

2022-04-01 to 2022-06-30

1,191,000
Source

10-Q · 2023-05-15 · 0001213900-23-039875

2023-01-01 to 2023-03-31

1,452,000
Source

10-Q · 2023-05-15 · 0001213900-23-039875

2022-01-01 to 2022-03-31

———1,502,000
Source

10-K · 2023-04-17 · 0001213900-23-030228

2022-01-01 to 2022-12-31

Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD———————————8,130,000
Source

10-K · 2023-04-17 · 0001213900-23-030228

2022-01-01 to 2022-12-31

Net Income (Loss) Attributable to ParentUSD—————-2,983,000
Source

6-K/A · 2023-08-18 · 0001213900-23-068745

2022-04-01 to 2022-06-30

-3,515,000
Source

10-Q · 2023-05-15 · 0001213900-23-039875

2023-01-01 to 2023-03-31

-2,475,000
Source

10-Q · 2023-05-15 · 0001213900-23-039875

2022-01-01 to 2022-03-31

-8,307,000
Source

20-F · 2026-04-01 · 0001213900-26-038011

2025-01-01 to 2025-12-31

4,796,000
Source

20-F · 2025-05-07 · 0001213900-25-040402

2024-01-01 to 2024-12-31

-6,500,000
Source

20-F · 2024-05-15 · 0001213900-24-043560

2023-01-01 to 2023-12-31

-5,796,000
Source

10-K · 2023-04-17 · 0001213900-23-030228

2022-01-01 to 2022-12-31

Net Income (Loss) Available to Common Stockholders, BasicUSD——————————6,415,000
Source

20-F · 2024-05-15 · 0001213900-24-043560

2023-01-01 to 2023-12-31

—
Nonoperating Income (Expense)USD————-1,167,000
Source

6-K/A · 2023-08-18 · 0001213900-23-068745

2023-04-01 to 2023-06-30

280,000
Source

6-K/A · 2023-08-18 · 0001213900-23-068745

2022-04-01 to 2022-06-30

-329,000
Source

10-Q · 2023-05-15 · 0001213900-23-039875

2023-01-01 to 2023-03-31

140,000
Source

10-Q · 2023-05-15 · 0001213900-23-039875

2022-01-01 to 2022-03-31

-765,000
Source

20-F · 2026-04-01 · 0001213900-26-038011

2025-01-01 to 2025-12-31

-1,325,000
Source

20-F · 2025-05-07 · 0001213900-25-040402

2024-01-01 to 2024-12-31

—5,265,000
Source

10-K · 2023-04-17 · 0001213900-23-030228

2022-01-01 to 2022-12-31

Operating ExpensesUSD————————4,890,000
Source

20-F · 2026-04-01 · 0001213900-26-038011

2025-01-01 to 2025-12-31

8,058,000
Source

20-F · 2025-05-07 · 0001213900-25-040402

2024-01-01 to 2024-12-31

9,706,000
Source

20-F · 2024-05-15 · 0001213900-24-043560

2023-01-01 to 2023-12-31

—
Other Depreciation and AmortizationUSD——————————514,000
Source

20-F · 2024-05-15 · 0001213900-24-043560

2023-01-01 to 2023-12-31

—
Other Nonoperating Income (Expense)USD————————-359,000
Source

20-F · 2026-04-01 · 0001213900-26-038011

2025-01-01 to 2025-12-31

-1,422,000
Source

20-F · 2025-05-07 · 0001213900-25-040402

2024-01-01 to 2024-12-31

—5,100,000
Source

10-K · 2023-04-17 · 0001213900-23-030228

2022-01-01 to 2022-12-31

Other Operating Income (Expense), NetUSD———————————5,265,000
Source

10-K · 2023-04-17 · 0001213900-23-030228

2022-01-01 to 2022-12-31

Payments for Repurchase of WarrantsUSD————————59,000
Source

20-F · 2026-04-01 · 0001213900-26-038011

2025-01-01 to 2025-12-31

59,000
Source

20-F · 2025-05-07 · 0001213900-25-040402

2024-01-01 to 2024-12-31

59,000
Source

20-F · 2024-05-15 · 0001213900-24-043560

2023-01-01 to 2023-12-31

—
Proceeds from Issuance of Common StockUSD—————————2,000,000
Source

20-F · 2025-05-07 · 0001213900-25-040402

2024-01-01 to 2024-12-31

139,000
Source

20-F · 2024-05-15 · 0001213900-24-043560

2023-01-01 to 2023-12-31

—
Revenue from Contract with Customer, Including Assessed TaxUSD—————————389
Source

20-F · 2025-05-07 · 0001213900-25-040402

2024-01-01 to 2024-12-31

——
Profit or Loss——
Source

6-K/A · 2021-12-27 · 0001213900-21-067430

2021-07-01 to 2021-09-30

————
Source

6-K/A · 2022-08-29 · 0001213900-22-051844

2022-04-01 to 2022-06-30

——————
AdjustmentsForSharebasedPayments——
Source

6-K/A · 2021-12-27 · 0001213900-21-067430

2021-07-01 to 2021-09-30

————
Source

6-K/A · 2022-08-29 · 0001213900-22-051844

2022-04-01 to 2022-06-30

——————
PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities——
Source

6-K/A · 2021-12-27 · 0001213900-21-067430

2021-07-01 to 2021-09-30

————
Source

6-K/A · 2022-08-29 · 0001213900-22-051844

2022-04-01 to 2022-06-30

——————

Lines labelled “Derived” are calculated from reported figures.

income statement · annual statements
Line itemQ4 2021Q3 2021Q2 2023Q2 2022Q1 2023Q1 2022FY 2025FY 2024FY 2023FY 2022
Total RevenueUSD——————1,311,000
Source

20-F · 2026-04-01 · 0001213900-26-038011

2025-01-01 to 2025-12-31

658,000
Source

20-F · 2025-05-07 · 0001213900-25-040402

2024-01-01 to 2024-12-31

——
Cost of Goods and Services Sold———————
Source

20-F · 2026-04-01 · 0001213900-26-038011

2025-01-01 to 2025-12-31

—
Source

20-F · 2025-05-07 · 0001213900-25-040402

2024-01-01 to 2024-12-31

——
Selling, General and Administrative ExpenseUSD——————2,521,000
Source

20-F · 2026-04-01 · 0001213900-26-038011

2025-01-01 to 2025-12-31

2,526,000
Source

20-F · 2025-05-07 · 0001213900-25-040402

2024-01-01 to 2024-12-31

4,505,000
Source

20-F · 2024-05-15 · 0001213900-24-043560

2023-01-01 to 2023-12-31

5,296,000
Source

10-K · 2023-04-17 · 0001213900-23-030228

2022-01-01 to 2022-12-31

Operating Income (Loss)USD———-3,263,000
Source

6-K/A · 2023-08-18 · 0001213900-23-068745

2022-04-01 to 2022-06-30

-3,186,000
Source

10-Q · 2023-05-15 · 0001213900-23-039875

2023-01-01 to 2023-03-31

-2,615,000
Source

10-Q · 2023-05-15 · 0001213900-23-039875

2022-01-01 to 2022-03-31

-7,542,000
Source

20-F · 2026-04-01 · 0001213900-26-038011

2025-01-01 to 2025-12-31

-8,638,000
Source

20-F · 2025-05-07 · 0001213900-25-040402

2024-01-01 to 2024-12-31

9,706,000
Source

20-F · 2024-05-15 · 0001213900-24-043560

2023-01-01 to 2023-12-31

-11,061,000
Source

10-K · 2023-04-17 · 0001213900-23-030228

2022-01-01 to 2022-12-31

Other Nonoperating Income (Expense)USD——————-359,000
Source

20-F · 2026-04-01 · 0001213900-26-038011

2025-01-01 to 2025-12-31

-1,422,000
Source

20-F · 2025-05-07 · 0001213900-25-040402

2024-01-01 to 2024-12-31

—5,100,000
Source

10-K · 2023-04-17 · 0001213900-23-030228

2022-01-01 to 2022-12-31

Net Income (Loss) Attributable to ParentUSD———-2,983,000
Source

6-K/A · 2023-08-18 · 0001213900-23-068745

2022-04-01 to 2022-06-30

-3,515,000
Source

10-Q · 2023-05-15 · 0001213900-23-039875

2023-01-01 to 2023-03-31

-2,475,000
Source

10-Q · 2023-05-15 · 0001213900-23-039875

2022-01-01 to 2022-03-31

-8,307,000
Source

20-F · 2026-04-01 · 0001213900-26-038011

2025-01-01 to 2025-12-31

4,796,000
Source

20-F · 2025-05-07 · 0001213900-25-040402

2024-01-01 to 2024-12-31

-6,500,000
Source

20-F · 2024-05-15 · 0001213900-24-043560

2023-01-01 to 2023-12-31

-5,796,000
Source

10-K · 2023-04-17 · 0001213900-23-030228

2022-01-01 to 2022-12-31

Earnings Per Share, BasicUSD per share——-0
Source

6-K/A · 2023-08-18 · 0001213900-23-068745

2023-04-01 to 2023-06-30

-0
Source

6-K/A · 2023-08-18 · 0001213900-23-068745

2022-04-01 to 2022-06-30

-0
Source

10-Q · 2023-05-15 · 0001213900-23-039875

2023-01-01 to 2023-03-31

-0
Source

10-Q · 2023-05-15 · 0001213900-23-039875

2022-01-01 to 2022-03-31

——-0
Source

20-F · 2024-05-15 · 0001213900-24-043560

2023-01-01 to 2023-12-31

-0.01
Source

10-K · 2023-04-17 · 0001213900-23-030228

2022-01-01 to 2022-12-31

Earnings Per Share, DilutedUSD per share——-0
Source

6-K/A · 2023-08-18 · 0001213900-23-068745

2023-04-01 to 2023-06-30

-0
Source

6-K/A · 2023-08-18 · 0001213900-23-068745

2022-04-01 to 2022-06-30

-0
Source

10-Q · 2023-05-15 · 0001213900-23-039875

2023-01-01 to 2023-03-31

-0
Source

10-Q · 2023-05-15 · 0001213900-23-039875

2022-01-01 to 2022-03-31

——-0
Source

20-F · 2024-05-15 · 0001213900-24-043560

2023-01-01 to 2023-12-31

-0.01
Source

10-K · 2023-04-17 · 0001213900-23-030228

2022-01-01 to 2022-12-31

Weighted Average Number of Shares Outstanding, Basicshares——1,351,850,046
Source

6-K/A · 2023-08-18 · 0001213900-23-068745

2023-04-01 to 2023-06-30

746,898,671
Source

6-K/A · 2023-08-18 · 0001213900-23-068745

2022-04-01 to 2022-06-30

1,295,256,604
Source

10-Q · 2023-05-15 · 0001213900-23-039875

2023-01-01 to 2023-03-31

744,711,465
Source

10-Q · 2023-05-15 · 0001213900-23-039875

2022-01-01 to 2022-03-31

9,339,460,965
Source

20-F · 2026-04-01 · 0001213900-26-038011

2025-01-01 to 2025-12-31

3,225,472,266
Source

20-F · 2025-05-07 · 0001213900-25-040402

2024-01-01 to 2024-12-31

1,562,627,495
Source

20-F · 2024-05-15 · 0001213900-24-043560

2023-01-01 to 2023-12-31

754,076,407
Source

10-K · 2023-04-17 · 0001213900-23-030228

2022-01-01 to 2022-12-31

Weighted Average Number of Shares Outstanding, Dilutedshares——1,351,850,046
Source

6-K/A · 2023-08-18 · 0001213900-23-068745

2023-04-01 to 2023-06-30

746,898,671
Source

6-K/A · 2023-08-18 · 0001213900-23-068745

2022-04-01 to 2022-06-30

1,295,256,604
Source

10-Q · 2023-05-15 · 0001213900-23-039875

2023-01-01 to 2023-03-31

744,711,465
Source

10-Q · 2023-05-15 · 0001213900-23-039875

2022-01-01 to 2022-03-31

9,339,460,965
Source

20-F · 2026-04-01 · 0001213900-26-038011

2025-01-01 to 2025-12-31

3,225,472,266
Source

20-F · 2025-05-07 · 0001213900-25-040402

2024-01-01 to 2024-12-31

1,562,627,495
Source

20-F · 2024-05-15 · 0001213900-24-043560

2023-01-01 to 2023-12-31

754,076,407
Source

10-K · 2023-04-17 · 0001213900-23-030228

2022-01-01 to 2022-12-31

Additional Financial Items
Depreciation, Depletion and Amortization, NonproductionUSD——————1,421,000
Source

20-F · 2026-04-01 · 0001213900-26-038011

2025-01-01 to 2025-12-31

1,649,000
Source

20-F · 2025-05-07 · 0001213900-25-040402

2024-01-01 to 2024-12-31

——
General and Administrative ExpenseUSD—6,201,000
Source

6-K/A · 2021-12-27 · 0001213900-21-067430

2021-07-01 to 2021-09-30

1,141,000
Source

6-K/A · 2023-08-18 · 0001213900-23-068745

2023-04-01 to 2023-06-30

1,289,000
Source

6-K/A · 2023-08-18 · 0001213900-23-068745

2022-04-01 to 2022-06-30

1,191,000
Source

10-Q · 2023-05-15 · 0001213900-23-039875

2023-01-01 to 2023-03-31

1,452,000
Source

10-Q · 2023-05-15 · 0001213900-23-039875

2022-01-01 to 2022-03-31

———1,502,000
Source

10-K · 2023-04-17 · 0001213900-23-030228

2022-01-01 to 2022-12-31

Gross ProfitUSD——————-2,652,000
Source

20-F · 2026-04-01 · 0001213900-26-038011

2025-01-01 to 2025-12-31

-580,000
Source

20-F · 2025-05-07 · 0001213900-25-040402

2024-01-01 to 2024-12-31

——
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD—————————8,130,000
Source

10-K · 2023-04-17 · 0001213900-23-030228

2022-01-01 to 2022-12-31

Interest ExpenseUSD————————343,000
Source

20-F · 2024-05-15 · 0001213900-24-043560

2023-01-01 to 2023-12-31

—
Interest Expense, DebtUSD————————2,968,000
Source

20-F · 2024-05-15 · 0001213900-24-043560

2023-01-01 to 2023-12-31

—
Investment Income, NetUSD——————765,000
Source

20-F · 2026-04-01 · 0001213900-26-038011

2025-01-01 to 2025-12-31

1,325,000
Source

20-F · 2025-05-07 · 0001213900-25-040402

2024-01-01 to 2024-12-31

3,206,000
Source

20-F · 2024-05-15 · 0001213900-24-043560

2023-01-01 to 2023-12-31

—
Net Income (Loss) Available to Common Stockholders, BasicUSD————————6,415,000
Source

20-F · 2024-05-15 · 0001213900-24-043560

2023-01-01 to 2023-12-31

—
Nonoperating Income (Expense)USD——-1,167,000
Source

6-K/A · 2023-08-18 · 0001213900-23-068745

2023-04-01 to 2023-06-30

280,000
Source

6-K/A · 2023-08-18 · 0001213900-23-068745

2022-04-01 to 2022-06-30

-329,000
Source

10-Q · 2023-05-15 · 0001213900-23-039875

2023-01-01 to 2023-03-31

140,000
Source

10-Q · 2023-05-15 · 0001213900-23-039875

2022-01-01 to 2022-03-31

-765,000
Source

20-F · 2026-04-01 · 0001213900-26-038011

2025-01-01 to 2025-12-31

-1,325,000
Source

20-F · 2025-05-07 · 0001213900-25-040402

2024-01-01 to 2024-12-31

—5,265,000
Source

10-K · 2023-04-17 · 0001213900-23-030228

2022-01-01 to 2022-12-31

Operating ExpensesUSD——————4,890,000
Source

20-F · 2026-04-01 · 0001213900-26-038011

2025-01-01 to 2025-12-31

8,058,000
Source

20-F · 2025-05-07 · 0001213900-25-040402

2024-01-01 to 2024-12-31

9,706,000
Source

20-F · 2024-05-15 · 0001213900-24-043560

2023-01-01 to 2023-12-31

—
Other ExpensesUSD——————788,000
Source

20-F · 2026-04-01 · 0001213900-26-038011

2025-01-01 to 2025-12-31

1,516,000
Source

20-F · 2025-05-07 · 0001213900-25-040402

2024-01-01 to 2024-12-31

941,000
Source

20-F · 2024-05-15 · 0001213900-24-043560

2023-01-01 to 2023-12-31

—
Other Operating Income (Expense), NetUSD—————————5,265,000
Source

10-K · 2023-04-17 · 0001213900-23-030228

2022-01-01 to 2022-12-31

Research and Development ExpenseUSD—2,024,000
Source

6-K/A · 2021-12-27 · 0001213900-21-067430

2021-07-01 to 2021-09-30

—1,974,000
Source

6-K/A · 2023-08-18 · 0001213900-23-068745

2022-04-01 to 2022-06-30

1,995,000
Source

10-Q · 2023-05-15 · 0001213900-23-039875

2023-01-01 to 2023-03-31

1,163,000
Source

10-Q · 2023-05-15 · 0001213900-23-039875

2022-01-01 to 2022-03-31

2,369,000
Source

20-F · 2026-04-01 · 0001213900-26-038011

2025-01-01 to 2025-12-31

5,532,000
Source

20-F · 2025-05-07 · 0001213900-25-040402

2024-01-01 to 2024-12-31

5,210,000
Source

20-F · 2024-05-15 · 0001213900-24-043560

2023-01-01 to 2023-12-31

5,765,000
Source

10-K · 2023-04-17 · 0001213900-23-030228

2022-01-01 to 2022-12-31

Revenue from Contract with Customer, Including Assessed TaxUSD———————389
Source

20-F · 2025-05-07 · 0001213900-25-040402

2024-01-01 to 2024-12-31

——
Undistributed Earnings (Loss) Allocated to Participating Securities, BasicUSD——————8,307,000
Source

20-F · 2026-04-01 · 0001213900-26-038011

2025-01-01 to 2025-12-31

-4,796,000
Source

20-F · 2025-05-07 · 0001213900-25-040402

2024-01-01 to 2024-12-31

——
BasicEarningsLossPerShare——
Source

6-K/A · 2021-12-27 · 0001213900-21-067430

2021-07-01 to 2021-09-30

——
Source

6-K/A · 2022-08-29 · 0001213900-22-051844

2022-04-01 to 2022-06-30

——————
DeferredTaxExpenseIncomeRecognisedInProfitOrLoss————
Source

6-K/A · 2022-08-29 · 0001213900-22-051844

2022-04-01 to 2022-06-30

——————
DilutedEarningsLossPerShare——
Source

6-K/A · 2021-12-27 · 0001213900-21-067430

2021-07-01 to 2021-09-30

——
Source

6-K/A · 2022-08-29 · 0001213900-22-051844

2022-04-01 to 2022-06-30

——————
FinanceCosts——
Source

6-K/A · 2021-12-27 · 0001213900-21-067430

2021-07-01 to 2021-09-30

——
Source

6-K/A · 2022-08-29 · 0001213900-22-051844

2022-04-01 to 2022-06-30

——————

Lines labelled “Derived” are calculated from reported figures.

Offerings

Registration 333-299674

F-3 · 2026-10-28 · 0001213900-26-113294

Terms from the governing filing for this registration; not a claim that the offering is open today.

Registration 333-299112

F-1 · 2026-09-24 · 0001213900-26-103067

Terms from the governing filing for this registration; not a claim that the offering is open today.

Registration 333-290437

POS AM · 2026-08-27 · 0001213900-26-094234

Terms from the governing filing for this registration; not a claim that the offering is open today.

Registration 333-295698

F-3 · 2026-05-08 · 0001213900-26-053855

Terms from the governing filing for this registration; not a claim that the offering is open today.

Filing attachments

ea031106001ex99-1.htm · 6-K · 2026-11-09

Exhibit 99.1 Scinai Reports Significant Revenue Growth in First Nine Months of 2026 as CDMO Business Expands October agreement advances the U.S. customer program to approximately $5.1 million in committed base services JERUSALEM, Nov. 5, 2026 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) (“Scinai” or the “Company”), a biopharmaceutical company operating a contract development and manufacturing organization (“CDMO”) alongside an immunology-focused therapeutic development platfo…

6-K · 2026-11-09 · 0001213900-26-117154

Read attachment ↗
ea030984201ex4-5.htm · F-3 · 2026-10-28

Exhibit 4.5 THE REGISTERED HOLDER OF THIS PURCHASE WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS PURCHASE WARRANT EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS PURCHASE WARRANT AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR HYPOTHECATE THIS PURCHASE WARRANT FOR A PERIOD OF ONE HUNDRED EIGHTY (180) DAYS FOLLOWING THE INITIAL EXERCISE DATE (DEFINED BELOW) TO ANYONE OTHER THAN (I) A.G.P./ALLIANCE GLOBAL PARTNERS OR ANOTHER PLACEMEN…

F-3 · 2026-10-28 · 0001213900-26-113294

Read attachment ↗
ea030914301ex99-1.htm · 6-K · 2026-10-20

Exhibit 99.1 Scinai CEO Updates Shareholders on CDMO Growth and Extended Runway Following Completed Financing Management estimates operating runway to late 2027, with potential extension into the third quarter of 2028 as later project phases under the recently announced CDMO agreement are activated and delivered JERUSALEM, Oct. 20, 2026 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) today issued the following letter to shareholders from Chief Executive Officer Amir Reichman. D…

6-K · 2026-10-20 · 0001213900-26-110869

Read attachment ↗
ea030885201ex99-1.htm · 6-K · 2026-10-16

Exhibit 99.1 Scinai Immunotherapeutics Announces Closing of $4.0 Million Financing Through a Private Placement and Warrant Inducement JERUSALEM, October 16, 2026 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) (“Scinai” or the “Company”), a biopharmaceutical company operating a growing contract development and manufacturing organization (“CDMO”) alongside an immunology-focused therapeutic development platform, today announced the closing of its previously announced private placem…

6-K · 2026-10-16 · 0001213900-26-110069

Read attachment ↗
ea030860501ex4-1.htm · 6-K · 2026-10-15

Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSA…

6-K · 2026-10-15 · 0001213900-26-109633

Read attachment ↗
ea030860501ex4-2.htm · 6-K · 2026-10-15

Exhibit 4.2 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSA…

6-K · 2026-10-15 · 0001213900-26-109633

Read attachment ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.